Choosing the first biologic in pediatric Crohn's disease: Evidence, uncertainty, and the continuing role of anti-TNF therapy

Best Practice & Research Clinical Gastroenterology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles